Trial Profile
A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2017
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors Changchun Keygen Biological Products
- 29 Aug 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 29 Aug 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 02 Jul 2014 New trial record